Literature DB >> 8027768

Activity-dependent expression and distribution of M1 muscarinic ACh receptors in visual cortex neuronal cultures.

Y Wang1, Q Gu, F Mao, R P Haugland, M S Cynader.   

Abstract

The fluorescently labeled muscarinic M1 receptor-selective antagonist BODIPY FL pirenzepine has been employed to study the activity-dependent distribution and expression of muscarinic M1 ACh receptors (M1AChRs) in cultured neurons derived from rat visual cortex. Displacement experiments showed that like pirenzepine, binding of BODIPY FL pirenzepine was specific to M1 receptors and its K(i) was similar to that of unlabeled pirenzepine. Using confocal laser scanning microscopy, M1 receptors were predominantly localized to cell bodies early in development in the culture environment. After 2 weeks in culture, the receptors showed labeling not only in cell bodies but also in neuritic processes, especially on the initial segments of the processes. Chronic membrane depolarization with 40 mM potassium chloride caused a dramatic increase in M1 receptor expression on these neurons. Conversely, blockade of neuronal activity with 0.1 microM TTX decreased expression of the receptors. Receptor expression increased after cells were treated chronically with 50 nM pirenzepine, whereas it decreased after exposure to 10 microM carbachol. The results demonstrate for the first time the exact location of muscarinic receptors in living cultured neurons and also the activity-dependent expression of M1 receptors on these neurons. Both chronic membrane depolarization and antagonist application upregulate receptor expression, whereas blocking bioelectrical activity or chronic agonist application downregulates expression.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8027768      PMCID: PMC6577025     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  8 in total

1.  Bidirectional modulation of visual plasticity by cholinergic receptor subtypes in the frog optic tectum.

Authors:  Chuan-Jiang Yu; Christopher M Butt; Elizabeth A Debski
Journal:  Eur J Neurosci       Date:  2003-03       Impact factor: 3.386

2.  Effect of the M1 Muscarinic Acetylcholine Receptor on Retinal Neuron Number Studied with Gene-Targeted Mice.

Authors:  Panagiotis Laspas; Jan J Sniatecki; Christoph Brochhausen; Andreas Steege; Evgeny Goloborodko; Marcin L Kordasz; Franz H Grus; Norbert Pfeiffer; Adrian Gericke
Journal:  J Mol Neurosci       Date:  2015-02-28       Impact factor: 3.444

3.  Differently fluorescence-labelled dibenzodiazepinone-type muscarinic acetylcholine receptor ligands with high M2R affinity.

Authors:  Corinna G Gruber; Andrea Pegoli; Christoph Müller; Lukas Grätz; Xueke She; Max Keller
Journal:  RSC Med Chem       Date:  2020-06-08

Review 4.  Functionalized congener approach to the design of ligands for G protein-coupled receptors (GPCRs).

Authors:  Kenneth A Jacobson
Journal:  Bioconjug Chem       Date:  2009-04-30       Impact factor: 4.774

Review 5.  Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing.

Authors:  Preeti Gupta; M Sinead O'Mahony
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 6.  Molecular probes for muscarinic receptors: functionalized congeners of selective muscarinic antagonists.

Authors:  K A Jacobson; B Fischer; A M van Rhee
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

7.  Adaptation to prolonged neuromodulation in cortical cultures: an invariable return to network synchrony.

Authors:  Maya Kaufman; Sebastian Reinartz; Noam E Ziv
Journal:  BMC Biol       Date:  2014-10-23       Impact factor: 7.431

8.  Cell cycle reentry triggers hyperploidization and synaptic dysfunction followed by delayed cell death in differentiated cortical neurons.

Authors:  E Barrio-Alonso; A Hernández-Vivanco; C C Walton; G Perea; J M Frade
Journal:  Sci Rep       Date:  2018-09-25       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.